SCHEMBL5018977

SCHEMBL5018977

CN[C@H](C(=O)Nc1ccc2ncccc2c1)[C@H](O[Si](C)(C)C(C)(C)C)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.44
RAB9A P51151 5/20 0.44
POLB P06746 2/20 0.44
PABPC1 P11940 1/20 0.44
BRAF P15056 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.42
TRPV1 Q8NER1 1/20 0.40
NOTUM Q6P988 1/20 0.39
HDAC1 Q13547 2/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
ROCK2 O75116 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5018833 0.89 NPC1 (0.43) NPC1RAB9APOLBPABPC1BRAF
SCHEMBL5018972 0.84 TRPM8 (0.35) NPC1RAB9APOLBPABPC1BRAF
SCHEMBL5019155 0.79 EGFR (0.36) NPC1RAB9APOLBPABPC1BRAF
SCHEMBL5185570 0.76 NPC1 (0.53) NPC1RAB9APOLBPABPC1BRAF
SCHEMBL5018934 0.75 AKR1C3 (0.39) NPC1RAB9ATRPV1CNR2
SCHEMBL3958875 0.72 NPC1 (0.76) NPC1RAB9APOLBPABPC1BRAF
SCHEMBL4949380 0.70 NPC1 (0.51) NPC1RAB9APOLBPABPC1BRAF
SCHEMBL30544185 0.69 BRAF (0.52) NPC1RAB9APOLBPABPC1BRAF
SCHEMBL29099848 0.69 BRAF (0.52) NPC1RAB9APOLBPABPC1BRAF
SCHEMBL5024166 0.69 MCHR1 (0.51) NPC1RAB9APOLBPABPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178490-B2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2012-05-15 US disclosed
US-20100152098-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF MPEX PHARMACEUTICALS, INC. (US) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152098-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF ABCB11, ABCB1, SLC47A1 NPC1 124/4885RAB9A 495/4885POLB 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.